5'-Atp → HCID 178507181, compound
Reaction equation
P([O:9][CH2:10][C@H:11]1[O:15][C@@H:14]([N:16]2[C:25]3[N:24]=[CH:23][N:22]=[C:20]([NH2:21])[C:19]=3[N:18]=[CH:17]2)[C@H:13]([OH:26])[C@@H:12]1[OH:27])(OP(O)(O)=O)(=O)O.P(OC[C@H]1O[C@@H](N2C3N=CN=C(N)C=3N=C2)[C@H](O)[C@@H]1O)(OP(OP(O)(O)=O)(O)=O)(=O)[OH:29]>>[C@@H:14]1([N:16]2[C:25]3[C:19](=[C:20]([N+:22]([O-:29])=[CH:23][N:24]=3)[NH2:21])[N:18]=[CH:17]2)[O:15][C@H:11]([CH2:10][OH:9])[C@@H:12]([OH:27])[C@H:13]1[OH:26]Participants
3
Reactant 2
Product 1
Procedure
5′-Adenosine triphosphate N1-oxide with a purity of 98% or higher was obtained similarly as in the above procedure except for replacing the above adenosine 5′-diphosphate with adenosine 5′-triphosphate with a product code of P0756L, commercialized by New England Biolabs Japan Inc., Tokyo, Japan.
Sources & evidence
- ORD record
- ord-2319d86f15e5429588d50180b898ed82
- Source dataset
- uspto-grants-2016_03
- Patent number
- US09295627B2
Reaction notes
Loading…